Related Experiment Video
Updated: Aug 8, 2026
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1
María de Haro1, Ismael Al-Ramahi, Beatrice De Gouyon
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by a CTG expansion in the 3' UTR of the dystrophia myotonica protein kinase (DMPK) gene. It has been hypothesized that the pathogenesis in DM1 is triggered by a toxic gain of function of the expanded DMPK RNA. This expanded RNA is retained in nuclear foci where it sequesters and induces alterations in the levels of RNA-binding proteins (RNA-BP). To model DM1 and study the implication of RNA-BP in CUG-induced toxicity, we have generated a Drosophila DM1 model expressing a non-coding mRNA containing 480 interrupted CUG repeats; i.e. [(CUG)20CUCGA]24. This (iCUG)480 transcript accumulates in nuclear foci and its expression leads to muscle wasting and degeneration in Drosophila. We also report that altering the levels of two RNA-BP known to be involved in DM1 pathogenesis, MBNL1 and CUGBP1, modify the (iCUG)480 degenerative phenotypes. Expanded CUG-induced toxicity in Drosophila is suppressed when MBNL1 expression levels are increased, and enhanced when MBNL1 levels are reduced. In addition, (iCUG)480 also causes a decrease in the levels of soluble MBNL1 that is sequestered in the CUG-containing nuclear foci. In contrast, increasing the levels of CUGBP1 worsens (iCUG)480-induced degeneration even though CUGBP1 distribution is not altered by the expression of the expanded triplet repeat. Our data supports a mechanism for DM1 pathogenesis in which decreased levels of MBNL and increased levels of CUGBP mediate the RNA-induced toxicity observed in DM1. Perhaps more importantly, they also provide proof of the principle that CUG-induced muscle toxicity can be suppressed.
Insights
Myotonic dystrophy type 1 (DM1) pathogenesis involves toxic RNA gain-of-function. Modulating RNA-binding proteins MBNL1 and CUGBP1 in a Drosophila model suppressed or enhanced DM1-related muscle degeneration, offering therapeutic insights.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- Myotonic dystrophy type 1 (DM1) is a genetic neuromuscular disorder.
- DM1 pathogenesis is linked to expanded CTG repeats in the DMPK gene, leading to toxic RNA gain-of-function.
- Expanded RNA forms nuclear foci, sequestering RNA-binding proteins (RNA-BPs).
Purpose of the Study:
- To develop a Drosophila model for DM1 to investigate CUG-induced toxicity.
- To examine the role of specific RNA-BPs, MBNL1 and CUGBP1, in DM1 pathogenesis.
- To explore potential therapeutic strategies by manipulating RNA-BP levels.
Main Methods:
- Generated a Drosophila model expressing an interrupted CUG repeat transcript [(CUG)20CUCGA]24 (iCUG480).
- Analyzed the accumulation of (iCUG)480 in nuclear foci and its impact on muscle tissue.
- Manipulated the expression levels of MBNL1 and CUGBP1 in the Drosophila model to assess their effects on DM1 phenotypes.
Main Results:
- The (iCUG)480 transcript formed nuclear foci and caused muscle wasting and degeneration in Drosophila.
- Increased MBNL1 levels suppressed (iCUG)480-induced toxicity, while decreased MBNL1 levels enhanced it.
- Increased CUGBP1 levels exacerbated degeneration, despite no change in CUGBP1 distribution.
Conclusions:
- DM1 pathogenesis involves decreased MBNL1 and increased CUGBP1, mediating RNA-induced toxicity.
- Altered MBNL1 levels impact CUG-induced toxicity, with sequestration of soluble MBNL1 in nuclear foci observed.
- This study provides proof-of-principle that CUG-induced muscle toxicity can be suppressed, suggesting therapeutic potential.
